Immunotherapy Is Fastest Growing Segment Fueling The Growth Of Kidney Cancer Drugs Market


https://www.coherentmarketinsights.com/market-insight/kidney-cancer-drugs-market-2399
Kidney Cancer Drugs Market


The global Kidney Cancer Drugs Market Size is estimated to be valued at US$ 6.2 Bn in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Kidney cancer drugs are used for treatment of renal cell carcinoma (RCC), which is the most common type of kidney cancer in adults. These drugs help improve survival and quality of life of patients by slowing or stopping the growth and spread of cancerous cells.

Market key trends:
Immunotherapy has emerged as one of the most promising treatment approaches for kidney cancer in recent years. Drugs that boost the body's natural defenses to fight cancer such as checkpoint inhibitors are being increasingly used. Key PD-1 and PD-L1 inhibitors approved for kidney cancer include Opdivo (nivolumab) and Keytruda (pembrolizumab). These drugs have shown superior efficacy compared to existing targeted therapy drugs with tolerable safety profiles. Furthermore, combination immunotherapies using two or more immune checkpoint inhibitors together are gaining traction and demonstrating encouraging response rates in clinical trials for kidney cancer. The better safety profile and durable response rates provided by immunotherapy drugs is expected to drive higher adoption and growth of this segment over the forecast period.
Segment Analysis
The global kidney cancer drugs market is segmented based on drug type, treatment type, end-user, and region. By drug type, the tyrosine kinase inhibitors segment dominated the market in 2022 as these drugs have revolutionized kidney cancer treatment, with better efficacy and tolerability compared to previous therapies. Tyrosine kinase inhibitors effectively inhibit vascular endothelial growth factor receptors and are used as first-line treatment for advanced and metastatic renal cell carcinoma.

Key Takeaways
The global kidney cancer drugs market is expected to witness high growth, exhibiting CAGR of 6.4% over the forecast period, due to increasing incidence of kidney cancer and adoption of advanced targeted therapies.

Regional analysis
Regionally, North America dominated the global kidney cancer drugs market in 2022 and is expected to retain its dominance over the forecast period. Higher awareness regarding early detection of kidney cancer and strong presence of key market players in the region is responsible for its large share.

Key players
Key players operating in the kidney cancer drugs market are Pfizer Inc., Novartis International AG, Genentech, Inc., Active Biotech AB, Amgen Inc., Bayer AG, Cipla Limited, Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Eisai Co., Ltd., and Exelixis, Inc. These players are focusing on developing advanced targeted therapies to expand their product portfolios. Read More: https://www.dailyprbulletin.com/targeted-therapies-to-boost-the-growth-of-kidney-cancer-drugs-market-size-and-share-analysis/

Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more